Given Imaging Announces Studies Confirming Value Of Reflux & Manometry Products

(RTTNews) - Given Imaging (GIVN) reported numerous studies confirming the value of its reflux and manometry products in diagnosing, monitoring and managing a range of gastrointestinal diseases. Results of over 110 trials of Given Imaging's products were presented at United European Gastroenterology or UEG Week this year exhibited the breadth and utility of its portfolio.

Mark Fox, M.D., Division of Gastroenterology of University Hospital Zurich said: "New tools like high-resolution manometry and prolonged pH monitoring deliver more detailed and more relevant information that allow us to explain the causes of patient symptoms and to better manage patients with esophageal disorders."

Presenter Daphne Ang M.D., of Changi General Hospital, Department of Gastroenterology, Singapore, showed data from a study comprising 2925 patients that targeted to determine the diagnostic yield of functional studies performed on and off proton pump inhibitor or PPI therapy.

Investigators concluded that among those GERD patients with insufficient treatment response, improved diagnostic yield was achieved with multichannel intraluminal impedance-wireless pH monitoring performed on PPI therapy for evaluation of non-acid reflux and off therapy for acid reflux evaluation, the company noted.